Not all injection drug users are created equal: Heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia

Substance Use and Misuse

Volumn 43, Issue 10, 2008, Pages 1424-1437

  Kuniholm, Mark H ^a   Aladashvili, Malvina ^b   Rio, Carlos Del ^c   Stvilia, Ketavan ^b   Gabelia, Nino ^b,c   Chitale, Rohit A ^a   Tsertsvadze, Tengiz ^b   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b AIDS and Clinical Immunology Research Center   (Georgia)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caucasus region; Epidemiology; Former Soviet Union; Georgia; Hepatitis B virus; Hepatitis C virus; Heroin; HIV; Injection drug users; Synthetic drugs

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; OPIATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG USE; FEMALE; GEORGIA (REPUBLIC); HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; FEMALE; GEORGIA (REPUBLIC); HEPATITIS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; QUESTIONNAIRES; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 49449099772     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802108293     Document Type: Article

References (30)

1. Alcabes, P., Friedland, G. (1995). Injection drug use and human immunodeficiency virus infection. Clinical Infectious Diseases 20:1467-1479.
2. Boileau, C., Bruneau, J., Al Nachawati, H., Lamothe, F., Vincelette, J. (2005). A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials. Journal of Acquired Immune Deficiency Syndromes 39:489-495.
3. Butsashvili, M., Tsertsvadze, T., McNutt, L. A., Kamkamidze, G., Gvetadze, R., Badridze, N. (2001). Prevalence of hepatitis B, hepatitis C, syphilis and HIV in Georgian blood donors. European Journal of Epidemiology 17:693-695.
4. DeBell, D., Carter, R. (2005). Impact of transition on public health in Ukraine: case study of the HIV/AIDS epidemic. British Medical Journal 331:216-219.
5. Delage, G., Infante-Rivard, C., Chiavetta, J. A., Willems, B., Pi, D., Fast, M. (1999). Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology 116:893-899.
6. Diaz, T., Des, J., Vlahov, D., Perlis, T. E., Edwards, V., Friedman, S. R., et al. (2001). Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health 91:23-30.
7. Girardi, E., Zaccarelli, M., Tossini, G., Puro, V., Narciso, P., Visco, G. (1990). Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scandinavian Journal of Infectious Diseases 22:751-752.
8. Kazionny, B., Wells, C. D., Kluge, H., Gusseynova, N., Molotilov, V. (2001). Implications of the growing HIV-1 epidemic for tuberculosis control in Russia. Lancet 358:1513-1514.
9. Kelly, J. A., Amirkhanian, Y. A. (2003). The newest epidemic: a review of HIV/AIDS in Central and Eastern Europe. International Journal of STD and AIDS 14:361-371.
10. McMahon, B. J. (2005). Epidemiology and natural history of hepatitis B. Seminars in Liver Disease 25(Suppl. 1):3-8.
11. Mikhailov, M. I., Gomberg, M. A., Dolzhanskaya, N. A., Koubanova, A. A. (2002). Significance of sexual route of transmission of hepatitis B and C in Russia. International Journal of STD and AIDS 13(Suppl 2):9-11.
12. Millson, P., Myers, T., Calzavara, L., Wallace, E., Major, C., Degani, N. (2003). Regional variation in HIV prevalence and risk behaviours in Ontario injection drug users (IDU). Canadian Journal of Public Health 94:431-435.
13. Parfitt T. (2006). Designer drug Subutex takes its toll in Tbilisi. Lancet 368:273-274.
14. Rhodes, T., Lowndes, C., Judd, A., Mikhailova, L. A., Sarang, A., Rylkov, A., et al. (2002). Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 16:F25-F31.
15. Rhodes, T., Platt, L., Maximova, S., Koshkina, E., Latishevskya, N., Hickman, M., et al. (2006). Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 101:252-266.
16. Sanchez, J. L., Todd, C. S., Bautista, C. T., Botros, B. A., Khakimov, M. M., Giyasova, G. M., et al. (2006). High HIV prevalence and risk factors among injection drug users in Tashkent, Uzbekistan, 2003-2004. Drug and Alcohol Dependence 82(Suppl 1):S15-22.
17. Shakarishvili, A., Dubovskaya, L. K., Zohrabyan, L. S., St Lawrence, J. S., Aral, S. O., Dugasheva, L. G., et al. (2005). Sex work, drug use, HIV infection, and spread of sexually transmitted infections in Moscow, Russian Federation. Lancet 366:57-60.
18. Shapatava, E., Nelson, K. E., Tsertsvadze, T., del Rio, C. (2006). Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia. Drug and Alcohol Dependence 82(Suppl 1):S35-S38.
19. Shepard, C. W., Finelli, L., Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 5:558-567.
20. Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., et al. (2001) Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Archives of Internal Medicine 161:1281-1288.
21. Stvilia, K., Tsertsvadze, T., Sharvadze, L., Aladashvili, M., del Rio, C., Kuniholm, M. H., et al. (2006). Prevalence of Hepatitis C, HIV, and Risk Behaviors for Blood-Borne Infections: A Population-Based Survey of the Adult Population of T'bilisi, Republic of Georgia. Journal of Urban Health 83:289-298.
22. Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., et al. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 74:212-220.
23. Tkeshelashvilli-Kessler, A., del Rio, C., Nelson, K., Tsertsvadze, T. (2005). The emerging HIV/AIDS epidemic in Georgia. International Journal of STD and AIDS 16:61-67.
24. United Nations Office for Drug Control and Crime Prevention. (2002). Illicit drug situation in the regions neighboring Afganistan and response of ODCCP.
25. United Nations Office on Drugs and Crime. (2005). World Drug Report 2005.
26. United States Department of State. (1996).1996 International Narcotics Control Strategy Report.
27. United States Department of State. (2005). 2005 International Narcotics Control Strategy Report
28. United States Drug Enforcement Administration. (2003). Heroin Trafficking in Russia's Troubled East. DEA-03053
29. Vu, M. Q., Steketee, R. W., Valleroy, L., Weinstock, H., Karon, J., Janssen, R. (2002). HIV incidence in the United States, 1978-1999. Journal of Acquired Immune Deficiency Syndromes 31:188-201.
30. Zaller, N., Nelson, K. E., Aladashvili, M., Badridze, N., del Rio, C., Tsertsvadze, T. (2004). Risk factors for hepatitis C virus infection among blood donors in Georgia. European Journal of Epidemiology 19:547-553.